Literature DB >> 24460719

Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells.

Q Yang1, M J Dahl, K H Albertine, R Ramchandran, M Sun, J U Raj.   

Abstract

OBJECTIVE: Pulmonary arterial hypertension, characterized by pulmonary vascular remodelling and vasoconstriction, is associated with excessive proliferative changes in pulmonary vascular walls. However, the role of HDACs in the phenotypic alteration of pulmonary arterial smooth muscle cells (PASMC) is largely unknown.
MATERIAL AND METHODS: Pulmonary arterial smooth muscle cells were isolated from newborn sheep. Cell cycle analysis was performed by flow cytometry. mRNA and protein expression were measured by real-time PCR and Western blot analysis. Wound-healing scratch assay was used to measure cell migration. Contractility of newborn PASMCs was determined by gel contraction assay. Chromatin immunoprecipitation was used to examine histone modifications along the p21 promoter region. Global DNA methylation was measured by liquid chromatography-mass spectroscopy.
RESULTS: Inhibition of class I and class II HDACs by apicidin and HDACi VIII suppressed proliferation of newborn PASMC and induced cell cycle arrest in G1 phase. Acetyl H3 levels were higher in newborn PASMC treated with apicidin and HDACi VIII. This was accompanied by increased expression of p21 and reduced expression of CCND1 but not p53. HDAC inhibition altered histone codes around the p21 promoter region in NPASMC. Apicidin inhibited serum-induced cell migration, and modulated profiling of expression of genes encoding pro-oxidant and antioxidant enzymes. Contractility and global DNA methylation levels of newborn PASMCs were also markedly modulated by apicidin.
CONCLUSION: Our results demonstrate that class I HDACs are clearly involved in phenotypic alteration of newborn PASMC.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24460719      PMCID: PMC3904681          DOI: 10.1111/cpr.12076

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  40 in total

Review 1.  Epigenetics and the developmental origins of lung disease.

Authors:  Lisa A Joss-Moore; Kurt H Albertine; Robert H Lane
Journal:  Mol Genet Metab       Date:  2011-07-23       Impact factor: 4.797

Review 2.  Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development.

Authors:  Kohta Ikegami; Jun Ohgane; Satoshi Tanaka; Shintaro Yagi; Kunio Shiota
Journal:  Int J Dev Biol       Date:  2009       Impact factor: 2.203

3.  Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis.

Authors:  Jayasri Nanduri; Vladislav Makarenko; Vaddi Damodara Reddy; Guoxiang Yuan; Anita Pawar; Ning Wang; Shakil A Khan; Xin Zhang; Brian Kinsman; Ying-Jie Peng; Ganesh K Kumar; Aaron P Fox; Lucy A Godley; Gregg L Semenza; Nanduri R Prabhakar
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

4.  Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.

Authors:  J W Han; S H Ahn; S H Park; S Y Wang; G U Bae; D W Seo; H K Kwon; S Hong; H Y Lee; Y W Lee; H W Lee
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

5.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

6.  Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma.

Authors:  Qi-Wei Yang; Shuqing Liu; Yufeng Tian; Helen R Salwen; Alexandre Chlenski; Joanna Weinstein; Susan L Cohn
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

7.  Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.

Authors:  Qiwei Yang; Yufeng Tian; Kelly R Ostler; Alexandre Chlenski; Lisa J Guerrero; Helen R Salwen; Lucy A Godley; Susan L Cohn
Journal:  BMC Cancer       Date:  2010-06-14       Impact factor: 4.430

Review 8.  The role of redox signaling in epigenetics and cardiovascular disease.

Authors:  Gene H Kim; John J Ryan; Stephen L Archer
Journal:  Antioxid Redox Signal       Date:  2013-03-12       Impact factor: 8.401

9.  Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy.

Authors:  Ravi Goyal; Dipali Goyal; Arthur Leitzke; Ciprian P Gheorghe; Lawrence D Longo
Journal:  Reprod Sci       Date:  2009-11-18       Impact factor: 3.060

10.  Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.

Authors:  Lan Zhao; Chien-Nien Chen; Nabil Hajji; Eduardo Oliver; Emanuele Cotroneo; John Wharton; Daren Wang; Min Li; Timothy A McKinsey; Kurt R Stenmark; Martin R Wilkins
Journal:  Circulation       Date:  2012-06-18       Impact factor: 29.690

View more
  12 in total

Review 1.  Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.

Authors:  Bradley A Maron; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

Review 2.  Role of epigenetics in pulmonary hypertension.

Authors:  Tara V Saco; Prasanna Tamarapu Parthasarathy; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-09       Impact factor: 4.249

Review 3.  Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series).

Authors:  Soni S Pullamsetti; Frédéric Perros; Prakash Chelladurai; Jason Yuan; Kurt Stenmark
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

Review 4.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

5.  Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.

Authors:  Eva Nozik-Grayck; Crystal Woods; Robert S Stearman; Sujatha Venkataraman; Bradley S Ferguson; Kalin Swain; Russell P Bowler; Mark W Geraci; Kaori Ihida-Stansbury; Kurt R Stenmark; Timothy A McKinsey; Frederick E Domann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-27       Impact factor: 5.464

Review 6.  Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy.

Authors:  Matthew S Stratton; Timothy A McKinsey
Journal:  Biochem Cell Biol       Date:  2014-12-16       Impact factor: 3.626

7.  Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.

Authors:  Qiwei Yang; Archana Laknaur; Lelyand Elam; Nahed Ismail; Larisa Gavrilova-Jordan; John Lue; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2016-03-31       Impact factor: 3.060

8.  Genome-Wide H3K4me3 Analysis in Angus Cattle with Divergent Tenderness.

Authors:  Chunping Zhao; José A Carrillo; Fei Tian; Linsen Zan; Scott M Updike; Keji Zhao; Fei Zhan; Jiuzhou Song
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

9.  Identification and Classification of New Transcripts in Dorper and Small-Tailed Han Sheep Skeletal Muscle Transcriptomes.

Authors:  Tianle Chao; Guizhi Wang; Jianmin Wang; Zhaohua Liu; Zhibin Ji; Lei Hou; Chunlan Zhang
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

10.  The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids.

Authors:  Qiwei Yang; Sangeeta Nair; Archana Laknaur; Nahed Ismail; Michael P Diamond; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2016-02-17       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.